ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Biodesix Inc

Biodesix Inc (BDSX)

0.8063
-0.0559
(-6.48%)
Closed March 10 4:00PM
0.8739
0.0676
( 8.38% )
Pre Market: 8:07AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

BDSX News

Official News Only

BDSX Discussion

View Posts
georgie18 georgie18 5 days ago
BDSX...96...🥳

georgie18

Member Level
Re: georgie18 post# 18

Wednesday, March 05, 2025 12:01:26 PM

Post#
20
of 20
BDSX...92s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 670653

Wednesday, March 05, 2025 11:03:48 AM

Post#
676211
of 676223
BDSX....82...Off the .65 Bottom...🥳...Added this bottom...https://schrts.co/HFpbquXc

georgie18

Member Level
Re: None

Tuesday, January 07, 2025 7:47:47 AM

Post#
670653
of 676211
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html
πŸ‘οΈ0
georgie18 georgie18 6 days ago
BDSX...92s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 670653

Wednesday, March 05, 2025 11:03:48 AM

Post#
676211
of 676223
BDSX....82...Off the .65 Bottom...🥳...Added this bottom...https://schrts.co/HFpbquXc

georgie18

Member Level
Re: None

Tuesday, January 07, 2025 7:47:47 AM

Post#
670653
of 676211
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 6 days ago
BDSX....SLOW GRIND TO A DOLLA
πŸ‘οΈ0
georgie18 georgie18 6 days ago
BDSX....82...Off the .65 Bottom...🥳...Added this bottom...https://schrts.co/HFpbquXc

georgie18

Member Level
Re: None

Tuesday, January 07, 2025 7:47:47 AM

Post#
670653
of 676211
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 7 days ago
BDSX BOTTOM BUSTER
πŸ‘οΈ0
georgie18 georgie18 2 months ago
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html
πŸ‘οΈ0
PonkenPlonken PonkenPlonken 3 months ago
Mr Schuler is buying shares again
πŸ‘οΈ0
tw0122 tw0122 4 months ago
Is selling $250 million in stock fro time to time on the downside.. Separately, Biodesix filed a registration statement to sell up to $250 million in securities from time to time.
πŸ‘οΈ0
tw0122 tw0122 4 months ago
Lung diagnostics cancer revenues improving still has $33m cash $1.49 +'14%
πŸ‘οΈ0
AJ Freely AJ Freely 2 years ago
$BDSX - Up 12%/ Current Price $1.34.
Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules
πŸ‘οΈ0
1hot toddy 1hot toddy 2 years ago
WOOOOOOW 130K SHARES BUY NOW 2.6 MIL SHARE BUY $

3 MILLION $ BUY $$$$$$$$$$$$$$$$$$$$$$
πŸ‘οΈ0
Leg58 Leg58 2 years ago
Lots if potential but will public offering dilute price?
πŸ‘οΈ0
Leg58 Leg58 2 years ago
Lots if potential but will public offering dilute price?
πŸ‘οΈ0
subslover subslover 2 years ago
Earnings look good.
πŸ‘οΈ0
subslover subslover 2 years ago
Earnings look good.
πŸ‘οΈ0
MiamiGent MiamiGent 2 years ago
BDSX Has news this morning!

The contract covers the company’s entire lung diagnostic portfolio: Nodify XL2®, Nodify CDT®, VeriStrat®, GeneStrat® ddPCR, and GeneStrat NGSβ„’ testing.

https://investors.biodesix.com/news-releases/news-release-details/biodesix-awarded-us-federal-supply-schedule-contract-its

https://stockcharts.com/h-sc/ui?s=BDSX
πŸ‘οΈ0
carusso carusso 2 years ago
Not so much...
πŸ‘οΈ0
crudeoil24 crudeoil24 3 years ago
LET'S GO BDSX !!!!!
πŸ‘οΈ0
crudeoil24 crudeoil24 3 years ago
Biodesix to Participate in Two Upcoming Investor Conferences in September
6:00 am ET September 6, 2022 (BusinessWire) Print
Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will participate in two upcoming investor conferences:

Morgan Stanley 20th Annual Global Healthcare Conference Date: Tuesday, September 13, 2022 at 9:10 a.m. ET Format: Fireside Chat and 1x1 meetings Location: Sheraton Hotel, New York, NY Details: The fireside chat will be webcast live and available for replay under "News & Events" in the Investors section of the Company's website at www.biodesix.com.

H.C. Wainwright 24th Annual Global Investment Conference Dates: September 12-14, 2022 Format: 1x1 meetings Location: Lotte New York Palace Hotel, New York, NY
πŸ‘οΈ0
crudeoil24 crudeoil24 3 years ago
Biodesix, Inc. is a United States-based company engaged in developing and commercializing blood-based diagnostic tests for oncology. The Company’s product Biodesix Lung Reflex integrates genomic and proteomic blood-based results to reveal both sides of lung cancer. Its GeneStrat test offers blood-based mutation results within 72 hours for patients with non-small cell lung cancer (NSCLC). Its VeriStrat testing provides blood-based predictive and prognostic proteomic information with (NSCLC) who test negative for estimated glomerular filtration rate (EGFR) mutations (EGFR wild-type) or whose EGFR mutation status is unknown.
πŸ‘οΈ0
Leg58 Leg58 3 years ago
US based company is quietly trending up. IMHO.
GLTA
πŸ‘οΈ0